Antibody-toxin conjugates: a new approach to cancer therapy.
D000036:Abrin / Q000302:isolation & purification; D000906:Antibodies / Q000627:therapeutic use*; D000936:Antigen-Antibody Complex; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D004167:Diphtheria Toxin / Q000302:isolation & purification; D004353:Drug Evaluation, Preclinical / Q000379:methods; D006801:Humans; D007202:Indicators and Reagents; D008722:Methods; D009369:Neoplasms / Q000628:therapy*; D010940:Plant Proteins / Q000302:isolation & purification / Q000494:pharmacology; D012270:Ribosomes / Q000187:drug effects; D012276:Ricin / Q000302:isolation & purification; D012449:Safety; D014118:Toxins, Biological / Q000302:isolation & purification / Q000627:therapeutic use*
D000906:Antibodies; D000936:Antigen-Antibody Complex; D000970:Antineoplastic Agents; D004167:Diphtheria Toxin; D007202:Indicators and Reagents; D010940:Plant Proteins; D014118:Toxins, Biological; D000036:Abrin; D012276:Ricin